Telemark discloses 4.1% Biodesix (BDSX) stake in final Schedule 13G/A
Rhea-AI Filing Summary
Telemark Asset Management, Telemark Fund and Colin McNay have filed an Amendment No. 1 to their Schedule 13G for Biodesix, Inc., which they state is a final, “exit” filing. The reporting persons may be deemed to beneficially own 327,824 shares of Biodesix common stock, representing approximately 4.1% of the outstanding shares as of the event date.
All 327,824 shares are reported with shared voting and shared dispositive power and no sole voting or dispositive power. The filers certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Biodesix, but instead under the passive ownership standard applicable to Schedule 13G.
Positive
- None.
Negative
- None.
FAQ
What does the Telemark Schedule 13G/A say about its Biodesix (BDSX) ownership?
Why is this Biodesix (BDSX) Schedule 13G/A labeled an exit filing?
How much voting and dispositive power does Telemark report over Biodesix (BDSX) shares?
Does Telemark state an intent to influence control of Biodesix (BDSX)?
Who are the reporting persons in this Biodesix (BDSX) Schedule 13G/A?
What percentage threshold does the Biodesix (BDSX) 13G/A reference?